EARNEST Partners’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-210
| Closed | -$4.25K | – | 353 |
|
|
2023
Q3 | $4.25K | Hold |
210
| – | – | ﹤0.01% | 847 |
|
|
2023
Q2 | $5.37K | Hold |
210
| – | – | ﹤0.01% | 785 |
|
|
2023
Q1 | $6.25K | Hold |
210
| – | – | ﹤0.01% | 727 |
|
|
2022
Q4 | $5.68K | Hold |
210
| – | – | ﹤0.01% | 752 |
|
|
2022
Q3 | $5K | Hold |
210
| – | – | ﹤0.01% | 743 |
|
|
2022
Q2 | $6K | Hold |
210
| – | – | ﹤0.01% | 725 |
|
|
2022
Q1 | $7K | Hold |
210
| – | – | ﹤0.01% | 728 |
|
|
2021
Q4 | $7K | Hold |
210
| – | – | ﹤0.01% | 754 |
|
|
2021
Q3 | $7K | Hold |
210
| – | – | ﹤0.01% | 737 |
|
|
2021
Q2 | $8K | Hold |
210
| – | – | ﹤0.01% | 710 |
|
|
2021
Q1 | $9K | Hold |
210
| – | – | ﹤0.01% | 657 |
|
|
2020
Q4 | $10K | Hold |
210
| – | – | ﹤0.01% | 603 |
|
|
2020
Q3 | $7K | Hold |
210
| – | – | ﹤0.01% | 643 |
|
|
2020
Q2 | $6K | Hold |
210
| – | – | ﹤0.01% | 672 |
|
|
2020
Q1 | $6K | Hold |
210
| – | – | ﹤0.01% | 609 |
|
|
2019
Q4 | $7K | Hold |
210
| – | – | ﹤0.01% | 654 |
|
|
2019
Q3 | $8K | Hold |
210
| – | – | ﹤0.01% | 613 |
|
|
2019
Q2 | $9K | Hold |
210
| – | – | ﹤0.01% | 598 |
|
|
2019
Q1 | $9K | Hold |
210
| – | – | ﹤0.01% | 589 |
|
|
2018
Q4 | $9K | Hold |
210
| – | – | ﹤0.01% | 560 |
|
|
2018
Q3 | $14K | Buy |
+210
| New | +$13.5K | ﹤0.01% | 497 |
|
|
2018
Q2 | – | Sell |
-216
| Closed | -$10K | – | 1193 |
|
|
2018
Q1 | $10K | Hold |
216
| – | – | ﹤0.01% | 551 |
|
|
2017
Q4 | $10K | Buy |
+216
| New | +$9.93K | ﹤0.01% | 543 |
|
|
2017
Q1 | – | Sell |
-216
| Closed | -$8K | – | 297 |
|
|
2016
Q4 | $8K | Sell |
216
-76
| -26% | -$2.72K | ﹤0.01% | 561 |
|
|
2016
Q3 | $10K | Hold |
292
| – | – | ﹤0.01% | 337 |
|
|
2016
Q2 | $9K | Hold |
292
| – | – | ﹤0.01% | 350 |
|
|
2016
Q1 | $8K | Hold |
292
| – | – | ﹤0.01% | 360 |
|
|
2015
Q4 | $10K | Sell |
292
-5,309
| -95% | -$165K | ﹤0.01% | 349 |
|
|
2015
Q3 | $159K | Sell |
5,601
-36
| -0.6% | -$1.26K | ﹤0.01% | 220 |
|
|
2015
Q2 | $228K | Sell |
5,637
-1,392
| -20% | -$62.5K | ﹤0.01% | 214 |
|
|
2015
Q1 | $346K | Hold |
7,029
| – | – | ﹤0.01% | 208 |
|
|
2014
Q4 | $320K | Buy |
+7,029
| New | +$276K | ﹤0.01% | 214 |
|
Other funds holding AVNS
RC
WHG
PIM
EARNEST Partners's AVNS Position: Q4 2023 in Review
EARNEST Partners sold out of Avanos Medical (AVNS) in Q4 2023, closing a stake of 210 shares — an estimated $4.25K sold.
EARNEST Partners first reported a position in AVNS in Q4 2014 and held it in 32 quarters. The position peaked at $346K in Q1 2015. 265 funds tracked by Wall St. Rank hold AVNS as of Q4 2023.
- EARNEST Partners reported no remaining Avanos Medical position as of Q4 2023 after selling out during the quarter.
- EARNEST Partners sold 210 Avanos Medical shares in Q4 2023, an estimated $4.25K.
- EARNEST Partners first reported a position in Avanos Medical in Q4 2014 and held it in 32 quarters.
- EARNEST Partners's Avanos Medical position peaked at $346K in Q1 2015.
- 265 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2023.
Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.